Board of Directors
The Board comprises (i) five executive Directors, namely Mr. David Lin Kao Kun, Mr. Lu Zhiqiang, Mr. Chui Kwong Kau, Ms. Li Mei and Dr. Sun Yu; (ii) one non-executive Director, namely Ms. Lam Kuo; and (iii) four independent non-executive Directors, namely Mr. Hung Yat Ming, Mr. Chan Yun Hing, Mr. Gui Qiangfang and Mr. Zhang James Jian Yuen.
Chairman and Non-executive Director
Ms. Lam Kuo (“Ms. Lam”) was appointed as the nonexecutive Director and the chairman of the Board on 1 December 2012. Ms. Lam currently is the sub-director and the shareholder of GOLDEN DRAGON INTERNATIONAL AIR TRANSPORT COMPANY LIMITED. Ms. Lam has over 30 years’ business experience in the mainland China, Hong Kong and Macau region.
Vice Chairman and Executive Director
Mr. David Lin Kao Kun (“Mr. Lin”) was appointed as an executive Director and a vice chairman of the Board on 23 September 2013. Mr. Lin is also the directors of various subsidiaries of the Company. He has over 30 years’ experience in healthcare management. Mr. Lin is currently the shareholder and director of Healthcare Solution Investments Limited, Wei Xin Hospital Investments Management (Shanghai) Co., Ltd*, and Hope Bio-tech (Suzhou) Co., Ltd.
Chief Executive Officer and Executive Director
Mr. Lu Zhiqiang (“Mr. Lu”) was appointed as an executive Director and the chief executive officer of the Company on 30 September 2011. Mr. Lu is also the compliance officer, the authorized representative and the directors of various subsidiaries of the Company. He holds a Master of Business Administration Degree from Central State University of the United States of America and a Bachelor Degree in Engineering and a Bachelor Degree in Industry from Nanchang Hangkong University. Mr. Lu attended the program of a Master of Science Degree from the International Purchasing & Supply Chain Management Audencia NANTES.Ecole de Management. He is the leadership development chairperson of Lions Club in Shenzhen. Mr. Lu has many years’ experience in management and investment. He was the managing director of Chin Mining Investment Co., Ltd. Mr. Lu is an executive director of Extrawell Pharmaceutical Holdings Limited (stock code: 858). He was an executive director of Global Energy Resources International Group Limited (stock code: 8192) from 28 November 2014 to 2 September 2016 and a non-executive director of Lamtex Holdings Limited (formerly known as China New Energy Power Group Limited) (stock code: 1041) from 29 October 2014 to 9 July 2015.
Mr. Chui Kwong Kau (“Mr. Chui”) was appointed as a non-executive Director on 19 October 2009 and subsequently re-designated as an executive Director on 30 November 2009. Mr. Chui is also a member of the remuneration committee, the authorized representative, the agent for the service of process in Hong Kong and the directors of various subsidiaries of the Company. He has over 19 years’ experience in accounting and auditing fields including over 14 years’ experience in other listed companies. Mr. Chui is also a non-executive director of each of Hsin Chong Group Holdings Limited (stock code: 404), Ngai Shun Holdings Limited (stock code: 1246) and DeTai New Energy Group Limited (stock code: 559). He was an executive director of China Energy Development Holdings Limited (stock code: 228) from 05 October 2005 to 30 June 2016 and an independent non-executive director of Aurum Pacific (China) Group Limited (stock code: 8148) from 17 March 2010 to 16 March 2016.
Ms. Li Mei ("Ms. Li") was appointed as an executive Director on 14 December 2015. Ms. Li holds a degree of Master of Business Administration in Financial Management from York University, United States of America. Ms. Li has extensive experience in financial services business. She was an executive Director of the Company from 21 September 2012 to 1 August 2013 and an independent non-executive director of China Ocean Fishing Holdings Limited (formerly known as Sky Forever Supply Chain Management Group Limited, stock code: 8047) from 7 August 2015 to 2 August 2017.
Dr. Sun Yu ("Dr. Sun") was appointed as an executive Director on 7 August 2017. Dr. Sun holds a Doctor of Philosophy in Systems Design Engineering from University of Waterloo, Canada and a Bachelor Degree in Computer Application from 哈爾濱工業大學 (Harbin Institute of Technology*, China). Dr. Sun has over 10 years of experience in management and investment. Dr. Sun is a director of 北京西格碼列頓信息技術有限公司 (Beijing Xigmar Information Technology Limited*). He was a partner of 四川天府瑞領股權投資基金管理有限公司 (Sichuan Tianfu Realeader Investment Fund Management Corporation Ltd. *) from April 2016 to April 2017.
Independent Non-executive Directors
Mr. Hung Yat Ming (“Mr. Hung”) was appointed as an independent non-executive Director on 28 March 2013. Mr. Hung is also the chairman of each of the audit committee, the remuneration committee and the nomination committee of the Company. He graduated from The University of Hong Kong with a Bachelor degree in Mathematics and obtained a graduate diploma in Accounting from University of Strathclyde, Glasgow. Mr. Hung has over 30 years of experience in accounting and finance and is a financial controller of a Hong Kong listed company. He is a member of The Institute of Chartered Accountants of Scotland and Hong Kong Institute of Certified Public Accountants. Mr. Hung is an independent non-executive director of each of Asia Standard Hotel Group Limited (stock code: 292) and Asia Orient Holdings Limited (stock code: 214). He was an independent non-executive director of Sunway International Holdings Limited (stock code: 58) from 28 February 2013 to 20 May 2015.
Mr. Chan Yun Hing (“Mr. Chan”) was appointed as an independent non-executive Director on 21 September 2012.Mr. Chan is also the member of each of the audit committee, the remuneration committee and the nomination committee of the Company. He holds a degree of Master of Business Administration from Research Institute of Tsinghua University in Shenzhen (RITS), China — University of Wales. Mr. Chan is currently the director and consultant of Huizhou Da Ya Wan Hui Li Group Limited*. He is also the Standing Committee Member of Guangdong Huizhow of the Chinese People’s Political Consultative Conference, the Vice Chairman and the Secretary-General of Hong Kong Federation of Huichow Associations Limited and the Deputy Secretary-General of Hong Kong Federation of Guangdong Hakka Associations.
Mr. Gui Qiangfang (“Mr. Gui”) was appointed as an independent non-executive director of the Company on 21 September 2012. Mr. Gui is also the member of each of the audit committee, the remuneration committee and the nomination committee of the Company. He holds a degree of Doctor of Business Administration from California Southern University (formerly known as Southern California University for Professional Studies) and as a post-doctoral research fellow at California State University Monterey Bay. Mr. Gui is currently the chairman of the board of GN International Group and the chairman of World City Cooperation Organization Committee of China. He possesses the professional qualifications such as China Certified Real Estate Appraiser, Certified Public Valuer and Registered Land Valuer. Mr. Gui has over 20 years corporate experience and over 5 years working experience in the government of the People’s Republic of China.
Mr. Zhang James Jian Yuan ("Mr. Zhang") was appointed as an independent non-executive Director on 7 July 2017. Mr. Zhang holds a Master of Arts from Brooklyn College of the City University of New York and a Bachelor of Arts in Accounting from Jinan University in Guangzhou, China. Mr. Zhang has over 25 years of experience in financial and banking industry, including positions in private wealth management at Merrill Lynch and as a managing director of investment banking at TerraNova Capital Partners, Inc. Mr. Zhang is currently a director of BioLight Life Sciences Ltd, the shares of which are listed on Tel-Aviv Stock Exchange (Stock Code: BOLT). Mr. Zhang is a business partner with a substantial shareholder of the Company in two private companies incorporated in Hong Kong. Mr. Zhang is a minority shareholder and a director of these private companies.